Abstract
An overview of anticancer active spirocyclopropanes of the illudin class is provided. After a short introduction on the history and general chemistry of illudins M and S, new discoveries concerning their mode of action and metabolism are reported as well as new synthetic endeavors towards derivatives with improved selectivity for and efficacy against cancer cells. In addition, common and recently tapped biological sources and isolation procedures for known and new illudins are discussed. Pertinent literature is covered up to 2010.
Keywords: Alkylating agents, illudins, irofulven, anticancer drugs, fungal agents, spirocyclopropanes, metabolism, bionucleophiles, cyclophosphamide, basidiomycetes, lantern mushroom, mitomycins
Current Medicinal Chemistry
Title: Anticancer Active Illudins: Recent Developments of a Potent Alkylating Compound Class
Volume: 18 Issue: 6
Author(s): R. Schobert, S. Knauer, S. Seibt and B. Biersack
Affiliation:
Keywords: Alkylating agents, illudins, irofulven, anticancer drugs, fungal agents, spirocyclopropanes, metabolism, bionucleophiles, cyclophosphamide, basidiomycetes, lantern mushroom, mitomycins
Abstract: An overview of anticancer active spirocyclopropanes of the illudin class is provided. After a short introduction on the history and general chemistry of illudins M and S, new discoveries concerning their mode of action and metabolism are reported as well as new synthetic endeavors towards derivatives with improved selectivity for and efficacy against cancer cells. In addition, common and recently tapped biological sources and isolation procedures for known and new illudins are discussed. Pertinent literature is covered up to 2010.
Export Options
About this article
Cite this article as:
Schobert R., Knauer S., Seibt S. and Biersack B., Anticancer Active Illudins: Recent Developments of a Potent Alkylating Compound Class, Current Medicinal Chemistry 2011; 18 (6) . https://dx.doi.org/10.2174/092986711794927766
DOI https://dx.doi.org/10.2174/092986711794927766 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Proteasome Inhibition: A Promising Strategy for Treating Cancer, but What About Neurotoxicity?
Current Medicinal Chemistry Phytochemical Informatics and Virtual Screening of Herbs Used in Chinese Medicine
Current Pharmaceutical Design Nuclear Medicine: Proof of Principle for Targeted Drugs in Diagnosis and Therapy
Current Pharmaceutical Design Development of COX-2 Selective Inhibitors - Therapeutic Perspectives
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Novel Antiviral Strategies to Combat Human Arenavirus Infections
Current Molecular Medicine Brain Targeted Drug Delivery: Factors, Approaches and Patents
Recent Patents on Nanomedicine Regulation of Multidrug Resistance by Pro-Inflammatory Cytokines
Current Cancer Drug Targets Does the Immune System Regulate Mood to Defend against Infection? Evidence from Studies of Immune Factors, Depression, and Antidepressants
Current Psychiatry Reviews The Role of Melatonin in Multiple Sclerosis, Huntington's Disease and Cerebral Ischemia
CNS & Neurological Disorders - Drug Targets Muscarinic Acetylcholine Receptors: Relevance to Infertility and Male Contraception
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Heparan Sulphate as a Regulator of Leukocyte Recruitment in Inflammation
Current Protein & Peptide Science Hereditary Haemorrhagic Telangiectasia (HHT): Genetic and Molecular Aspects
Current Pharmaceutical Design Review of Medicinal Plants Common to Traditional Chinese and Indian Medicines with Relevance to Non-Communicable Diseases
Current Traditional Medicine The Effect of Temperature on the Interaction of Phenanthroline-based Ligands with G-quadruplex: In Silico Viewpoint
Combinatorial Chemistry & High Throughput Screening Utilizing Ultrasound to Transiently Increase Blood-Brain Barrier Permeability, Modulate of the Tight Junction Proteins, and Alter Cytoskeletal Structure
Current Neurovascular Research Biologic Therapies in Primary Sjögren's Syndrome
Current Pharmaceutical Biotechnology Death Receptors as Targets of Cancer Therapeutics
Current Cancer Drug Targets Mesoporous Materials and Nanocrystals for Enhancing the Dissolution Behavior of Poorly Water-soluble Drugs
Current Pharmaceutical Biotechnology Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients
Current Pharmaceutical Design Macronutrient Intake and Distribution in the Etiology, Prevention and Treatment of Osteosarcopenic Obesity
Current Aging Science